Form 4: Bioventus Inc. SVP & CFO Mark Leonard Singleton Reports Stock Transaction
SEC Form 4 Filing
Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reports the vesting of 13,000 restricted stock units and subsequent acquisition of Class A Common Stock on April 10, 2024.
Summary
- On April 10, 2024, Mark Leonard Singleton, the SVP & CFO of Bioventus Inc., had 13,000 restricted stock units (RSUs) vest.
- These RSUs converted into 13,000 shares of Class A Common Stock.
- Following the transaction, Singleton directly owns 38,665 shares of Class A Common Stock and 39,000 restricted stock units.
- The RSUs vest in four equal installments on each of the first four anniversaries of April 10, 2023, subject to continued service.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| April 10, 2023 | Initial date for RSU vesting schedule, with installments on each anniversary for four years. |
| April 10, 2024 | Date of transaction: vesting of 13,000 restricted stock units and acquisition of Class A Common Stock. |
| April 12, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.